AORT

1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M

YTD YTD

1 Year 1Y

5 Years 5Y

About Artivion Inc

Headquartered in suburban Atlanta, Georgia, CryoLife is a leader in the manufacturing, processing, and distribution of medical devices and implantable tissues used in cardiac and vascular surgical procedures focused on aortic repair. CryoLife markets and sells products in more than 100 countries worldwide.
CEO
James Mackin
Employees
1200
Headquarters

1655 Roberts Blvd NW
Kennesaw, Georgia 30144-3632
Phone: 17704193355
www.cryolife.com

News

Artivion Announces Release Date and Teleconference Call Details for First Quarter 2024 Financial Results
Apr 22, 2024 20:10pm

ATLANTA, April 22, 2024 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, announced today that first quarter 2024 financial results will be released on Monday, May 6, 2024 after the market closes. On that day, the…


Source:PR Newswire
Artivion files automatic mixed securities shelf
Mar 01, 2024 14:56pm

No summary available.


Source:Seeking Alpha